Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human SPOCK1 ELISA Kit (AC3909)
Cat.#: ASET-2498
Specifications
Description Human SPOCK1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human SPOCK1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.027 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.25-20 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2247 Human PON1 ELISA Kit (AC3658) Quantitative inquiry ASET-1878 Human NMDAR2B ELISA Kit (AC3289) Quantitative inquiry ASET-1796 Human iNOS ELISA Kit (AC3207) Quantitative inquiry ASET-2522 Human Nogo ELISA Kit (AC3933) Quantitative inquiry ASET-2031 Human Plexin A2 ELISA Kit (AC3442) Quantitative inquiry ASET-1735 Human NELL1 ELISA Kit (AC3146) Quantitative inquiry ASET-2518 Human HMGA2 ELISA Kit (AC3929) Quantitative inquiry ASET-1064 Mouse TSH beta ELISA Kit (AC2475) Quantitative inquiry ASET-1482 Human Ki67 ELISA Kit (AC2893) Quantitative inquiry ASET-2155 Rat MAdCAM1 ELISA Kit (AC3566) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket